| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.81▲ | 6.90▼ | 6.85▲ | 6.58▲ | 6.30▲ |
| MA10 | 6.85▲ | 6.82▲ | 6.76▲ | 6.21▲ | 6.89▼ |
| MA20 | 6.89▼ | 6.75▲ | 6.57▲ | 6.10▲ | 5.47▲ |
| MA50 | 6.82▲ | 6.53▲ | 6.27▲ | 6.69▲ | 3.26▲ |
| MA100 | 6.75▲ | 6.19▲ | 6.01▲ | 5.11▲ | 3.12▲ |
| MA200 | 6.56▲ | 6.01▲ | 6.45▲ | 3.37▲ | 5.42▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.018▼ | 0.004▲ | 0.019▲ | 0.131▲ | -0.018▼ |
| RSI | 50.492▲ | 58.844▲ | 62.167▲ | 56.893▲ | 61.334▲ |
| STOCH | 29.372 | 68.084 | 69.239 | 86.716▲ | 36.030 |
| WILL %R | -37.931 | -38.776 | -23.899▲ | -10.440▲ | -44.847 |
| CCI | -52.028 | -17.785 | 47.766 | 129.546▲ | 37.233 |
|
Friday, October 31, 2025 04:29 AM
Leerink Partners analyst Andrew Berens initiated coverage on Immuneering Corporation (NASDAQ: IMRX) with an Outperform rating and announced a price target of $15. Immuneering shares closed at $6.41 on ...
|
|
Friday, October 31, 2025 04:29 AM
Leerink Partners analyst Andrew Berens initiated coverage on Immuneering Corporation (NASDAQ: IMRX) with an Outperform rating and announced a price target of $15. Immuneering shares closed at $6.41 on ...
|
|
Tuesday, October 28, 2025 09:18 AM
Key Insights Immuneering's significant individual investors ownership suggests that the key decisions are influenced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/25 | 6.75 | 6.86 | 6.68 | 6.86 | 106,929 |
| 31/10/25 | 6.55 | 7.05 | 6.50 | 6.87 | 1,738,302 |
| 30/10/25 | 6.12 | 6.68 | 6.10 | 6.41 | 965,239 |
| 29/10/25 | 6.59 | 6.59 | 6.18 | 6.25 | 751,694 |
| 28/10/25 | 6.34 | 6.545 | 6.1325 | 6.49 | 939,006 |
| 27/10/25 | 6.04 | 6.44 | 5.92 | 6.30 | 1,112,157 |
| 24/10/25 | 5.74 | 6.19 | 5.65 | 6.04 | 1,080,001 |
| 23/10/25 | 5.36 | 5.67 | 5.32 | 5.63 | 875,600 |
| 22/10/25 | 5.78 | 5.84 | 5.23 | 5.35 | 1,433,492 |
| 21/10/25 | 5.55 | 5.915 | 5.45 | 5.85 | 1,084,214 |
|
|
||||
|
|
||||
|
|